Mangalam Drugs & Organics Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Mangalam Drugs & Organics and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 462 Mangalam Drugs & Organics employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Mangalam Drugs & Organics has purchased the following applications: Google Workspace (Formerly Google G-Suite) for Collaboration in 2016, Microsoft Dynamics NAV for ERP Financial in 2014 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Mangalam Drugs & Organics is running and its propensity to invest more and deepen its relationship with Google , Microsoft or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Mangalam Drugs & Organics revenues, which have grown to $56.2 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Mangalam Drugs & Organics intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.

x